Atezolizumab + Bevacizumab Shows Benefit in Met Renal CA

Progression - free survival benefit for patients with untreated metastatic renal cell carcinoma
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Nephrology, Oncology, Conference News, Source Type: news